این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Pediatric Hematology and Oncology، جلد ۷، شماره ۲، صفحات ۹۸-۱۰۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Quantitative Assessment of WT1 Expression by Real Time Quantitative PCR in Pediatric Patients with Acute Myeloblastic Leukemia
چکیده انگلیسی مقاله increment. It is categorized based on genetic aberrations. Some of these genetic disorders can determine minimal residual diseases (MRD) and prognosis of AML patients. Wilms tumor (WT1) over expression is found in AML patients. The aim of this study was to determine the frequency of WT1 over expression in AML pediatric cases in North -East of Iran. Materials and Methods: This retrospective Study was done in Mashhad, Iran during 2016 in 100 pediatric AML cases. WT1 expression was evaluated by quantitative reverses transcription PCR (qRT-PCR) and cloning method. Both WT1 and ABL genes were cloned to create a standard curve and then copy number of WT1 gene in patients was evaluated. Results: One hundred children under 15 with mean age of 6.50± 4.22 were evaluated in this study. There were no significant differences between age and sex and WT1 expression (P>0.05). Mean expression of cited gene was 200.52±210.62 copies of WT1/ABL 104 in studied samples. WT1 gene over expression was observed in 82% of all patients. Conclusion: WT1 assessment can be applied as a prognostic and diagnostic marker in AML patients under 15.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله حسین آیت اللهی | hossein ayatollahi
department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univer

سازمان های دیگر: Cancer Molecular Pathology Research Center

محمد هادی صادقیان | mohammad hadi sadeghian
department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univer

سازمان های دیگر: Cancer Molecular Pathology Research Center

سپیده شاکری | sepideh shakeri
cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

سیده فاطمه شمس | seyyede fatemeh shams
cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

مریم شیخی | maryam sheikhi
cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

محمد علیدادی | mohammad alidadi
cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

افسانه بهرامی | afsane bahrami
department of modern sciences and technology, school of medicine, mashhad university of medical sciences, mashhad,

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

ندا معتمدی راد | neda motamedi rad
cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (Mashhad university of medical sciences)

نشانی اینترنتی http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-70-121&slc_lang=en&sid=en
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/202/article-202-330861.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده 1
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات